Related Experiment Video
Updated: Apr 17, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
FKBP5/FKBP51 enhances autophagy to synergize with antidepressant action
Nils C Gassen1, Jakob Hartmann, Mathias V Schmidt
1a Department of Translational Research in Psychiatry ; Max Planck Institute of Psychiatry ; Munich , Germany.
Abstract:
Levels of autophagy markers rise upon treatment of cells with antidepressants. However, it was not known whether this phenomenon might be linked to other antidepressant pathways or to any physiological effect. In this punctum, we summarize and discuss our recent findings that provide evidence for a role of the cochaperone FKBP5/FKBP51 (FK506 binding protein 5) in autophagy as a prerequisite for antidepressant action in cells, mice, and humans. FKBP5 associates with BECN1, changes its phosphorylation and protein levels and enhances markers of autophagy and autophagic flux. The effects of antidepressants on autophagy as well as their physiological effects in mice and human depend on FKBP5.
Insights
Antidepressants increase autophagy, a cellular process. Our findings show the cochaperone FKBP5 (FK506 binding protein 5) is essential for this effect and for antidepressant action in cells, mice, and humans.
Area of Science:
- Neuroscience
- Cell Biology
- Molecular Biology
Background:
- Antidepressant treatment increases autophagy markers in cells.
- The precise role of autophagy in antidepressant action and its connection to other pathways remained unclear.
Purpose of the Study:
- To investigate the role of the cochaperone FKBP5 (FK506 binding protein 5) in mediating the autophagic effects of antidepressants.
- To determine if FKBP5 is a prerequisite for antidepressant action.
Main Methods:
- Studied the association of FKBP5 with BECN1.
- Assessed changes in FKBP5 phosphorylation and protein levels.
- Measured markers of autophagy and autophagic flux in cells, mice, and human samples.
- Investigated the dependence of antidepressant effects on FKBP5.
Main Results:
- FKBP5 associates with BECN1, altering its phosphorylation and protein levels.
- FKBP5 enhances autophagy markers and autophagic flux.
- The physiological effects of antidepressants in mice and humans are dependent on FKBP5.
Conclusions:
- FKBP5 plays a crucial role in autophagy.
- FKBP5 is a prerequisite for antidepressant action, influencing both cellular and physiological effects.
- Targeting FKBP5 may offer new therapeutic strategies for depression.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
G-protein Coupled Receptors
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...

